DE60322872D1 - Verfahren zur herstellung von säuresalzen von gemifloxacin - Google Patents

Verfahren zur herstellung von säuresalzen von gemifloxacin

Info

Publication number
DE60322872D1
DE60322872D1 DE60322872T DE60322872T DE60322872D1 DE 60322872 D1 DE60322872 D1 DE 60322872D1 DE 60322872 T DE60322872 T DE 60322872T DE 60322872 T DE60322872 T DE 60322872T DE 60322872 D1 DE60322872 D1 DE 60322872D1
Authority
DE
Germany
Prior art keywords
gemifloxacin
preparing salt
salt salts
salts
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322872T
Other languages
English (en)
Inventor
Hoon Choi
Sang-Chul Choi
Do-Hyun Nam
Bo-Seung Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Chem Ltd
Original Assignee
LG Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LG Life Sciences Ltd filed Critical LG Life Sciences Ltd
Application granted granted Critical
Publication of DE60322872D1 publication Critical patent/DE60322872D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60322872T 2002-04-08 2003-04-04 Verfahren zur herstellung von säuresalzen von gemifloxacin Expired - Lifetime DE60322872D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0018847A KR100517638B1 (ko) 2002-04-08 2002-04-08 게미플록사신 산염의 새로운 제조방법
PCT/KR2003/000683 WO2003087100A1 (en) 2002-04-08 2003-04-04 Process for preparing acid salts of gemifloxacin

Publications (1)

Publication Number Publication Date
DE60322872D1 true DE60322872D1 (de) 2008-09-25

Family

ID=36241771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322872T Expired - Lifetime DE60322872D1 (de) 2002-04-08 2003-04-04 Verfahren zur herstellung von säuresalzen von gemifloxacin

Country Status (32)

Country Link
US (1) US7361762B2 (de)
EP (1) EP1497290B1 (de)
JP (1) JP4315815B2 (de)
KR (1) KR100517638B1 (de)
CN (1) CN1291987C (de)
AP (1) AP1786A (de)
AT (1) ATE404559T1 (de)
AU (1) AU2003219581B2 (de)
BR (1) BRPI0309037B8 (de)
CA (1) CA2481217C (de)
CO (1) CO5611198A2 (de)
CY (1) CY1108469T1 (de)
DE (1) DE60322872D1 (de)
DK (1) DK1497290T3 (de)
EA (1) EA007222B1 (de)
ES (1) ES2311694T3 (de)
GE (1) GEP20074025B (de)
HK (1) HK1074440A1 (de)
HR (1) HRP20040929B1 (de)
IL (1) IL164328A (de)
IS (1) IS2731B (de)
MA (1) MA26408A1 (de)
MX (1) MXPA04009777A (de)
NO (1) NO330042B1 (de)
NZ (1) NZ536174A (de)
OA (1) OA12801A (de)
PL (1) PL372815A1 (de)
PT (1) PT1497290E (de)
SI (1) SI1497290T1 (de)
UA (1) UA77070C2 (de)
WO (1) WO2003087100A1 (de)
ZA (1) ZA200408088B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1412078T3 (da) * 2001-08-02 2009-02-02 Lg Life Sciences Ltd Fremgangsmåde til fremstilling af amino-beskyttede derivater af 4-aminomethylen-pyrrolidin-3-on, Gemifloxacin eller salte deraf
WO2006134431A1 (en) * 2005-05-03 2006-12-21 Ranbaxy Laboratories Limited Formate salt of gemifloxacin
EP1891037A1 (de) * 2005-06-15 2008-02-27 Hetero Drugs Limited Gemifloxacin-verfahren und - polymorphe
ZA200807674B (en) * 2006-03-07 2009-11-25 Wockhardt Ltd Prodrugs of benzoquinolizine-2-carboxylic acid
WO2008053324A1 (en) * 2006-10-31 2008-05-08 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of gemifloxacin mesylate

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134482A (en) 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
IN162769B (de) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
JPH0356479A (ja) 1989-07-24 1991-03-12 Takeshi Yokota 水溶性キノロン誘導体のp‐トルエンスルホン酸塩
IE66202B1 (en) 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
US5137892A (en) 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
US5276041A (en) 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives
JPH0673056A (ja) 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
DE69509442T2 (de) * 1994-06-16 1999-09-02 Lg Chemical Ltd. Chinolincarbonsäurederivate mit 7-(4-Amino-methyl-3-oxim)-pyrrolidin-Substituenten und Verfahren zu ihrer Herstellung
US5776944A (en) 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
JP3449658B2 (ja) 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法
ES2117426T3 (es) 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
RO120134B1 (ro) 1995-08-11 2005-09-30 Pfizer Inc. Trihidrat de metansulfonat de (1s, 2s)-1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol şi compoziţie farmaceutică
ATE239723T1 (de) 1996-03-29 2003-05-15 Smithkline Beecham Corp Eprosartandihydrat und ein verfahren zu seiner herstellung und formulierung
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
KR100286874B1 (ko) 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
AU4211799A (en) 1998-05-29 1999-12-13 Pharmacia & Upjohn Company 3-[(1--n-methylamino)ethyl-n-benzyl] pyrrolidine monomethanesulfonate
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
JP2003531101A (ja) 1999-06-29 2003-10-21 スミスクライン・ビーチャム・コーポレイション 細菌に対するフルオロキノロン化合物の使用法
EP1401440A4 (de) 1999-09-01 2006-07-05 Lg Life Sciences Ltd Verfahren zur verwendung von fluorchinolone verbindungen gegen bakterien
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
EP1561465A3 (de) 1999-09-22 2005-12-21 LG Life Sciences, Ltd. Verfahren zur Verwendung von fluorochinolonen Verbindungen gegen Bakterien
KR20010091379A (ko) 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
KR20020018560A (ko) 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-z-메톡시이미노피롤리딘의 신규 제조방법

Also Published As

Publication number Publication date
AU2003219581A1 (en) 2003-10-27
MA26408A1 (fr) 2004-12-01
JP2005529112A (ja) 2005-09-29
IS7477A (is) 2004-09-30
HRP20040929A2 (en) 2005-02-28
SI1497290T1 (sl) 2008-12-31
NZ536174A (en) 2006-09-29
MXPA04009777A (es) 2004-12-13
CN1649868A (zh) 2005-08-03
OA12801A (en) 2006-07-11
WO2003087100A1 (en) 2003-10-23
PT1497290E (pt) 2008-11-14
EP1497290A4 (de) 2006-05-10
NO330042B1 (no) 2011-02-07
ES2311694T3 (es) 2009-02-16
BR0309037A (pt) 2005-02-01
IL164328A (en) 2009-08-03
KR100517638B1 (ko) 2005-09-28
CO5611198A2 (es) 2006-02-28
EA200401328A1 (ru) 2005-06-30
AP1786A (en) 2007-10-04
NO20044629L (no) 2004-10-27
AU2003219581B2 (en) 2006-08-24
CN1291987C (zh) 2006-12-27
BRPI0309037B8 (pt) 2021-05-25
GEP20074025B (en) 2007-01-25
EP1497290B1 (de) 2008-08-13
DK1497290T3 (da) 2008-12-15
HK1074440A1 (en) 2005-11-11
IS2731B (is) 2011-04-15
ATE404559T1 (de) 2008-08-15
EP1497290A1 (de) 2005-01-19
IL164328A0 (en) 2005-12-18
PL372815A1 (en) 2005-08-08
BRPI0309037B1 (pt) 2018-07-31
AP2004003148A0 (en) 2004-12-31
JP4315815B2 (ja) 2009-08-19
EA007222B1 (ru) 2006-08-25
ZA200408088B (en) 2006-05-31
US7361762B2 (en) 2008-04-22
HRP20040929B1 (hr) 2013-12-06
CY1108469T1 (el) 2014-04-09
UA77070C2 (uk) 2006-10-16
KR20030080292A (ko) 2003-10-17
US20050148622A1 (en) 2005-07-07
CA2481217C (en) 2010-06-01
CA2481217A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
DE60336326D1 (de) Verfahren zur herstellung des calciumsalzes von rosuvastatin
DE602004026576D1 (de) Verbessertes verfahren zur herstellung vom rosuvastatin calcium salz
DE502004009768D1 (de) Verfahren zur herstellung von dreiwertigen organophosphor-verbindungen
DE602004004663D1 (de) Verfahren zur herstellung von 2- (chinoxalin-5-ylsulfonylamino) -benzamid-verbindungen
DE60323192D1 (de) Verfahren zur Herstellung von Hydroxyalkylstärkederivaten
DE60317690D1 (de) Verfahren zur herstellung von valsartan
DE60302139D1 (de) Verfahren zur herstellung von aripiprazole
DE50305954D1 (de) Verfahren zur herstellung eines pulverinhalativums enthaltend ein salz des cgrp-antagonisten bibn4096
DE60330050D1 (de) Verfahren zur herstellung von pyrimidinverbindungen
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
DE50207455D1 (de) Verfahren ZUR HERSTELLUNG VON CARBONSÄURESALZEN
ATE460414T1 (de) Verfahren zur herstellung von tiotropiumsalzen
DE602004021126D1 (de) Verfahren zur herstellung von n-amino-substituierten heterocyclischen verbindungen
ATE305919T1 (de) Verfahren zur herstellung von salzen der methallylsulfonsäure
DE60328756D1 (de) Verfahren zur herstellung von chiralen n-aryl piperazinen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE60322872D1 (de) Verfahren zur herstellung von säuresalzen von gemifloxacin
DE60322356D1 (de) Verfahren zur herstellung von 2-aminoindanderivaten
DE502004002810D1 (de) Verfahren zur herstellung von copolymerisaten
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen
DE602004029787D1 (de) Verfahren zur herstellung von 5-iodo-2-methylbenzoesäure
DE502004011176D1 (de) Verfahren zur hertellung von 2-cyan-3-hydroxy-n-(phenyl)but-2-enamiden
DE60307740D1 (de) Verfahren zur Desinfektion von Tierställen
DE502004011536D1 (de) verfahren zur herstellung von bengamide-derivaten
DE60330749D1 (de) Verfahren zur herstellung von 7-alpha-methylsteroide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition